Public Company News

Everest Medicines to Announce Full-Year 2021 Financial Results on March 29, 2022

SHANGHAI, March 15, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical unmet needs inAsia Pacific markets, today announced that it will...

2022-03-15 09:00 4107

Kuaishou's International Business Releases Its First Transparency Report.

More than 12 million videos were removed during the second-half year of 2021 on Kwai and SnackVideo, and the company aims to release the report every half year. SnackVideo in Indonesia and Kwai in Brazil launched various successful campaigns to fight against Covid-19 and fake news. BEIJING, Marc...

2022-03-15 08:00 2839

China Renaissance Announces Positive Profit Update

HONG KONG, March 14, 2022 /PRNewswire/ -- China Renaissance Holdings Limited ("China Renaissance" or the "Company"; stock code: 1911.HK) announced today that, based on the preliminary review of the unaudited consolidated management accounts for the year endedDecember 31, 2021, it expects to recor...

2022-03-14 22:02 3674

Nexteer Automotive & Tactile Mobility Announce Advanced Road & Tire Detection Software to Improve Vehicle Health Management, Safety & Performance

AUBURN HILLS, Mich., March 14, 2022 /PRNewswire/ -- Nexteer Automotive and Tactile Mobility have announced a software solution to improve overall vehicle health management, safety and performance by detecting changing road surfaces (wet, dry, icy, etc.)and evolving tire conditions (tire stiffness...

2022-03-14 21:05 5350

Secureworks® Hands-on-Keyboard Detector Identifies Malicious Threat Actors

Patent-pending Taegis™ platform detector uncovers "hands-on" cybercriminal activity even as the actors attempt to evade detection ATLANTA, March 14, 2022 /PRNewswire/ -- Secureworks® (NASDAQ: SCWX), a global leader in cybersecurity, today announced the addition of its Hands-on-Keyboard Detector ...

2022-03-14 21:00 2753

SOPHiA GENETICS and REALM IDx Sign Letter of Intent to Collaborate in Accelerating Cancer Research

The intended collaboration aims to help improve patient care by enhancing next-generation sequencing research for cancer care and expanding data sources for precision medicine. BOSTON, ALISO VIEJO, Calif. and LAUSANNE, Switzerland, March 14, 2022 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH) an...

2022-03-14 20:28 3084

Yum China Provides Update on the First Quarter 2022 Business Performance Amid the Latest COVID-19 Development in China

SHANGHAI, March 14, 2022 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China") (NYSE: YUMC and HKEX: 9987) today updated its first quarter 2022 business performance in light of the recent COVID-19 development in China. As we mentioned in the fourth quarter earnings release, sam...

2022-03-14 20:00 4712

Mycronic receives order for an SLX mask writer

STOCKHOLM, March 14, 2022 /PRNewswire/ -- Mycronic AB (publ) has received an order for an SLX mask writer from an existing customer inAsia. The order value is in the range ofUSD 4-6 million. Delivery of the system is planned for the third quarter of 2022. The SLX laser mask writer meets rising d...

2022-03-14 16:06 2471

Clarivate Deals Report Highlights Emerging Trends in Biopharma Deal-Making

RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology related deals dominate the landscape Biotech companies in U.S. awarded largest sums of capital, followed by Mainland China and UK LONDON, March 14, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in provid...

2022-03-14 16:00 2657

Aker Offshore Wind and Mainstream Renewable Power Close Transaction for Offshore Wind Development in Japan

OSLO, Norway, March 14, 2022 /PRNewswire/ -- With reference to the stock exchange notice on12 August 2021, Aker Offshore Wind and Mainstream Renewable Power ("Mainstream") have closed the transaction which will see them take an initial 50 percent ownership stake in Progression Energy's 800 MW flo...

2022-03-14 15:44 2703

Alphawave IP Announces Definitive Agreement to Acquire Entire OpenFive Business Unit from SiFive for US$210m in cash

Transaction will accelerate Alphawave's connectivity leadership, product offerings and customer base while driving higher scale and revenue growth from an expanded total addressable market LONDON, TORONTO and SAN MATEO, Calif., March 14, 2022 /PRNewswire/ -- Alphawave IP Group plc ("Alphawave" o...

2022-03-14 15:05 2564

ZIM to Launch ZIM eCommerce Baltimore eXpress (ZXB), a New Speedy eCommerce service from China and South-East Asia to the US East Coast

The New Service Expands ZIM's Speedy Premium Services for eCommerce Customers HAIFA, Israel, March 14, 2022 /PRNewswire/ -- ZIM Integrated Shipping Services Ltd.  (NYSE: ZIM) announced today the launch of  ZIM Ecommerce Baltimore Express (ZXB), a new and speedy e-commerce ser...

2022-03-14 10:00 4101

Gefen Releases a New Integrated BI Module

TEL AVIV, Israel, March 14, 2022 /PRNewswire/ -- Gefen (ASX: GFN) is announcing the release of a new BI (Business Intelligence) module for its software platform. The BI component generates custom reports that are based on aggregated data from across the gamut of ...

2022-03-14 08:14 2921

CStone announces the NMPA approval of GAVRETO (pralsetinib) for the treatment of Advanced or Metastatic RET-mutant medullary thyroid cancer and RET fusion-positive thyroid cancer

* GAVRETO is the first and only selective rearranged during transfection (RET) inhibitor approved inChina for the treatment of RET-mutant medullary thyroid cancer (MTC) and RET fusion-positive thyroid cancer (TC) * The labeled indications of GAVRETO have been expanded after it was approved by...

2022-03-14 08:05 4558

Latest Study Shows Advantages of CanSinoBIO's Convidecia™ as Heterologous Booster against Omicron Variant

TIANJIN, China, March 14, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SSE: 688185, HKEX: 06185) today announced that medRxiv, a preprint platform for preliminary biomedical research, published an academic paper1 on the efficacy of CanSinoBIO's Recombinant COVID-19 Vaccine ("Ad5-n...

2022-03-14 08:00 3755

Everest Medicines Enters into Agreement with Calliditas Therapeutics, Expanding Territory License to Develop and Commercialize NEFECON in South Korea

SHANGHAI, March 14, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical unmet needs inAsia Pacific markets, announced today that...

2022-03-14 08:00 4981

Addibond™ obtains Solar Impulse Efficient Solution Label

BRUSSELS, March 14, 2022 /PRNewswire/ -- Solvay's water-soluble Addibond™ polymer , used as a thin layer to strengthen bonding between aluminum a...

2022-03-14 08:00 4311

CIMC helps HK battle pandemic by offering over 2,000 units of modular buildings

SHENZHEN, China, March 14, 2022 /PRNewswire/ -- CIMC Modular Building System will provide a total of 2,076 units of modular buildings to helpHong Kong fight against the COVID-19 pandemic. Modular transitional house being hoisted  

2022-03-14 07:27 4615

Ascletis Announces Further Expansion of Ritonavir Oral Tablet Production Capacity to 530 Million Tablets Per Year

HANGZHOU, China and SHAOXING, China, March 13, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (Ascletis, HKEX: 1672) today announces that it has further expanded its ritonavir oral tablet production capacity to approximately 530 million tablets per year, to meet the potential escalation in the domesti...

2022-03-13 18:30 4723

Angel Yeast Steps Up Low-Carbon Measures in Green Push to Promote Global Sustainable Development

YICHANG, China, March 11, 2022 /PRNewswire/ -- Angel Yeast Co., Ltd ("Angel Yeast" or "the Company", 600298.SH), a listed global yeast and yeast extract manufacturer, has reached another recognition milestone for its green push towards the goal of carbon-neutrality ...

2022-03-11 20:30 6676
1 ... 771772773774775776777 ... 901